LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Kentucky KY
Legislatures
2025 Regular Session
House
Bills
HB384
KY
Kentucky House Bill HB384
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Kentucky 2025 Regular Session
Kentucky House Bill HB384
Introduced
2/6/25
Refer
2/6/25
Refer
2/12/25
Caption
AN ACT relating to intranasal epinephrine.
Latest KY HB384 Activity
View All Events: KY 2025 Regular Session HB384
Companion Bills
No companion bills found.
Previously Filed As
KY HB438
AN ACT relating to undesignated glucagon.
KY HB295
AN ACT relating to undesignated glucagon.
KY HB423
AN ACT relating to outdoor nature-based child care.
KY HB421
AN ACT relating to child care programs.
KY HB556
AN ACT relating to coverage for injectable epinephrine devices.
KY HB68
AN ACT relating to coverage for injectable epinephrine devices.
KY HB5
AN ACT relating to crimes and punishments.
KY HB353
AN ACT relating to crimes and punishments.
KY SB238
AN ACT relating to children.
KY HB274
AN ACT relating to the practice of pharmacy.
Similar Bills
HI HB1448
Relating To Asthma.
HI SB1443
Relating To Asthma.
HI SB1443
Relating To Asthma.
HI HB1448
Relating To Asthma.
HI SB531
Relating To Education.
HI HB903
Relating To Student Health.
MD HB86
Public and Nonpublic Schools - Bronchodilators - Use, Availability, Training, and Policies
MD SB180
Public and Nonpublic Schools - Bronchodilators - Use, Availability, Training, and Policies